Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ENVXW SEC filings page focuses on regulatory documents related to the Enovix Corporation warrants that traded under the ENVXW symbol. These filings help explain how the warrant program was structured, how it evolved over time, and how the ENVXW class was ultimately removed from listing on the Nasdaq Stock Market.
Key filings include multiple Form 8-K reports in which Enovix describes material events affecting the warrants. These 8-Ks summarize press releases announcing the distribution of the warrants as a dividend, the satisfaction of early expiration price conditions tied to the volume-weighted average price of Enovix common stock, the election of an alternate expiration date, and the mechanics by which warrants had to be exercised before they became void. The filings also reference a Notice of Guaranteed Delivery that outlined procedures for warrant holders whose financial institutions could not complete exercises before the deadline.
A central document for ENVXW is the Form 25 filed with the SEC, in which Nasdaq notified the Commission of the removal of the Enovix warrant class from listing and registration under Section 12(b) of the Exchange Act. This filing confirms that the ENVXW warrants, described simply as “Warrant” in the form, were struck from the exchange following the conclusion of the program.
Through Stock Titan, users can access these filings as they appear on EDGAR, while AI-powered tools can assist in interpreting the implications. For ENVXW, that means quickly understanding the timeline from warrant issuance to expiration, the conditions that triggered early expiration, and the formal delisting process. Users interested in Enovix more broadly can also look to related filings under ENVX for annual reports on Form 10-K, quarterly reports on Form 10-Q, and additional 8-Ks that discuss financial results, capital markets transactions and governance changes.
In addition, investors researching historical capital structure or derivative securities can use the ENVXW filings to see how the warrant terms were documented in the warrant agreement, how the company communicated with holders, and how proceeds from exercises were reported in subsequent disclosures. AI summaries can highlight the sections that address warrant exercise prices, expiration conditions, and the impact on Enovix’s equity.
Enovix Corp Chief Accounting Officer Kristina Truong reported a tax-withholding share disposition. On March 2, 2026, 1,260 shares of common stock were withheld at $5.45 per share to satisfy tax obligations tied to vested performance restricted stock units.
After this transaction, she directly owns 190,289 shares, including 137,235 shares issuable upon vesting and settlement of restricted stock units and 2,489 vested performance RSUs scheduled for release on March 2, 2027.
Enovix President and CEO Rajendra K. Talluri reported a tax-related share disposition on common stock. On March 2, 2026, 24,175 shares were withheld at $5.45 per share to satisfy tax obligations tied to vested performance RSUs. After this, he held 2,178,612 shares, including 1,446,958 issuable from RSUs and 47,775 vested PRSUs scheduled for release on March 2, 2027.
Enovix Corp Chief Legal Officer reports tax-related share withholding. Arthi Chakravarthy disposed of 5,259 shares of Enovix common stock on March 2, 2026 at $5.45 per share to cover tax withholding obligations tied to vested performance restricted stock units. After this tax-withholding disposition, direct holdings total 399,597 shares, which include 262,360 shares issuable upon vesting and settlement of restricted stock units and 10,393 vested performance RSUs scheduled for release on March 2, 2027.
Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a tax-withholding disposition of 2,221 shares of common stock on February 24, 2026, at $6.11 per share, to cover taxes on vested RSUs. Following this, she holds 404,856 shares, including unvested RSUs and performance RSUs with future release dates.
Enovix Corporation filed Amendment No. 1 to its Annual Report for the year ended December 28, 2025 to replace the consent of Deloitte & Touche LLP. The new consent now includes references to Enovix’s effective Registration Statements on Form S-3 (Nos. 333-275524, 333-273858, and 333-281260).
The amendment also files updated certifications from the principal executive officer and principal financial officer under Rules 13a-14(a) and 15d-14(a. It does not modify any financial statements or other disclosures in the original report and does not reflect events occurring after the original filing.
Enovix Corporation is a global battery company focused on designing, developing, manufacturing and commercializing advanced lithium-ion batteries using a proprietary 100% active silicon-anode architecture. Its AI-1™ platform targets smartphones, smart eyewear, defense, industrial and emerging edge-AI devices that require higher energy density in tight spaces.
The company has shifted from a broad, standard-cell strategy to deeper vertical programs with a smaller set of large OEM and ODM customers. Manufacturing has been consolidated into Fab2 in Malaysia and facilities in South Korea, supported by R&D centers in India and the U.S. A recent independent test showed the AI-1™ smartphone battery reached 935 Wh/L volumetric energy density.
Enovix highlights substantial risks: scaling a new and complex manufacturing process, achieving targeted throughput and yields, controlling raw material and production costs, and maintaining key third‑party manufacturing and supply relationships. It also notes a history of losses, a need for additional capital, customer concentration in certain sectors, global trade and geopolitical exposure, and the possibility that products under development may not reach commercial scale or expected performance.
Enovix Corporation reported strong top-line growth but continued losses, and expanded its share repurchase capacity. For full year 2025, revenue rose to $31.8 million from $23.1 million, a 38% increase, while GAAP gross margin improved to 19.2% from negative levels in 2024. Fourth quarter 2025 revenue reached $11.3 million, up from $9.7 million, with GAAP gross margin of 22.1%.
The company still posted a 2025 GAAP net loss of $156.7 million, though this narrowed from $222.2 million in 2024, and free cash flow improved to an outflow of $113.5 million from $184.8 million. Year-end cash, cash equivalents and marketable securities totaled about $621 million. Enovix’s board authorized an additional share repurchase program of up to $75 million, alongside remaining capacity of about $1.6 million under a prior plan. For first quarter 2026, the company forecasts revenue of $6.5–7.5 million and non-GAAP net loss per share of $0.14–0.18.
Enovix Corp Chief Accounting Officer Kristina Truong reported a tax-withholding disposition of 1,116 shares of common stock at $5.92 per share tied to RSU vesting. After this transaction, she holds 191,549 shares, including 139,724 RSUs and 4,978 vested PRSUs with future release dates.
Enovix Corp former Chief Operating Officer Ajay Marathe reported a tax-withholding disposition of 7,352 shares of common stock at $5.92 per share, tied to vesting of restricted stock units. After this withholding, he directly holds 313,893 shares. A separate disclosure notes cancellation of 596,596 RSUs, including 33,170 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027.
Enovix Corp’s Chief Accounting Officer Kristina Truong reported a small share disposition related to equity compensation. On February 10, 2026, 278 shares of common stock were withheld at $6.28 per share to cover tax obligations from vesting restricted stock units, rather than sold on the open market.
After this tax-withholding transaction, Truong beneficially owned 192,665 shares of Enovix common stock. This total includes 141,639 shares tied to unvested RSUs and 4,978 vested performance RSUs, with half of those PRSUs scheduled to be released on March 2, 2026 and the remainder on March 1, 2027.